REFERENCES

de Hoog G S, Dukik K, Monod M, Packeu A, Stubbe D et al. 2017 Toward a novel multilocus phylogenetic taxonomy for the dermatophytes Mycopathologia 182:5–31

Fox TC 1909 A further contribution to the study of the endothrix trichophyta flora in London, illustrated by a collection of cultures and photographs. Proc R Soc Med. 2(Dermatol Sect):49-66

Francuzik W, Fritz K, Salavastru C 2016 Laser therapies for onychomycosis - critical evaluation of methods and effectiveness. J Eur Acad Dermatol Venereol. 2016 30:936-942

Gräser Y, Monod M, Bouchara JP, Dukik K, Nenoff P, Kargl A, Kupsch C, Zhan P, Packeu A, Chaturvedi V, de Hoog S 2018 New insights in dermatophyte research. Med Mycol 56(suppl_1):2-9

Gupta AK, Hall S, Zane LT, Lipner SR, Rich P 2018 Evaluation of the efficacy and safety of tavaborole topical solution, 5%, in the treatment of onychomycosis of the toenail in adults: a pooled analysis of an 8-week, post-study follow-up from two randomized phase 3 studies. J Dermatolog Treat 29:44-48

Gupta AK, Studholme C 2016 Update on efinaconazole 10% topical Solution for the treatment of onychomycosis Skin Therapy Lett 21:7-11

Gupta AK, Versteeg SG, Shear NH 2017 Onychomycosis in the 21st Century: An Update on Diagnosis, Epidemiology, and Treatment J Cutaneous Med Surg 21 525–539

Gupta G, Foley KA, Gupta AK 2015 Tavaborole 5% Solution: A novel topical treatment for toenail onychomycosis. Skin Therapy Lett 20:6-9
Harrington BJ Hageage, Jr GJ 2003 Calcofluor white: A review of its uses and applications in clinical mycology and parasitologyLaboratory medicine 34: 361-367

Hay RJ 2017 Tinea Capitis: Current Status Mycopathologia 182: 87-93

Hay RJ, Baron R 2011 Onychomycosis: A proposed revision of the clinical classification J Amer Acad Dermatol 65:1219-1227

Kelly BP 2012 Superficial fungal infections. Pediatr Rev. 33: e22-e37

Kidd S, Halliday C, Alexiou H, Ellis D 2017 Descriptions of medical fungi. Third Ed. (rev) Newstyle Printing: Adelaide, Australia

Liddell LT, Rosen T 2015 Laser therapy for onychomycosis: fact or fiction? J Fungi 1: 44-54

Mashiah J, Kutz A, Ben Ami R, Savion M, Goldberg I, Gan Or T, Zidan O, Sprecher E, Harel A 2016 Tinea capitis outbreak among paediatric refugee population, an evolving healthcare challenge. Mycoses 59:553-557

Niewerth M, Kunze D, Seibold M, Schaller M, Korting HC, Hube B 2003. Ciclopirox olamine treatment affects the expression pattern of Candida albicans genes encoding virulence factors, iron metabolism proteins, and drug resistance factors. Antimicrob Agents Chemother 47:1805-1817

Panackal AA,Halpern EF, Watson AJ 2009 Cutaneous fungal infections in the United States: Analysis of the National Ambulatory Medical Care Survey (NAMCS) and National Hospital Ambulatory Medical Care Survey (NHAMCS), 1995–2004 Intern J Dermatol 48:704-712

Public Health England 2016 UK Standards for Microbiology Investigations: Investigation of Dermatological Specimens for Superficial Mycoses. Standards Unit, Microbiology Services, PHE Bacteriology B 39 No: 3.1 12/29/16 pp 1-26

Reiss E, Shadomy HJ, Lyon GM 2012 Fundamental Medical Mycology John Wiley and Sons Publishers, Hoboken NJ 624 p

Veasey JV, Avila RB, Miguel BA, Muramatu LH 2017 White piedra, black piedra, tinea versicolor, and tinea nigra: contribution to the diagnosis of superficial mycosis. Ann Bras Dermatol 92:413-416